# F-star Therapeutics Inc. (FSTX)

Source: https://www.quantisnow.com/company/FSTX
Generated: 2026-11-07T07:06:41.749Z

- Ticker: FSTX
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2016
- Website: f-star.com

## About

F-star Therapeutics, Inc., a clinical-stage biopharmaceutical company develops tetravalent bispecific antibodies for cancer therapy. Its medicines are used in immuno-oncology treatments. The company's principal product candidate is FS118, is currently being evaluated in a proof-of-concept Phase 2 trial in PD-1/PD-L1 acquired resistance head and neck cancer patients. It is also developing first-in-human clinical study of FS222, a bispecific antibody targeting CD137 (4-1BB) and PD-L1. The company was incorporated in 2002 and is headquartered in Cambridge, the United Kingdom.

## Latest FSTX news and filings

- 2024-07-08 12:15 UTC [Leadership Update] [Avacta Announces the Appointment of Darlene Deptula-Hicks as Non-Executive Director of the Board of Directors](https://www.quantisnow.com/insight/avacta-announces-the-appointment-of-darlene-deptula-hicks-as-non-executive-director-5596371)
- 2023-11-30 09:00 UTC [Leadership Update] [Levicept Appoints Eliot Forster as CEO](https://www.quantisnow.com/insight/levicept-appoints-eliot-forster-as-ceo-5109784)
- 2023-03-20 13:06 UTC [SEC Form 15-12G filed by F-star Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-15-12g-filed-by-f-star-therapeutics-inc-4223046)
- 2023-03-17 20:23 UTC [SEC Schedule 13G] [SEC Form SC 13G filed by F-star Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-by-f-star-therapeutics-inc-4219355)
- 2023-03-14 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by F-star Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-f-star-therapeutics-inc-4196077)
- 2023-03-14 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by F-star Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-f-star-therapeutics-inc-4196073)
- 2023-03-14 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by F-star Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-f-star-therapeutics-inc-4196057)
- 2023-03-14 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by F-star Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-f-star-therapeutics-inc-4196035)
- 2023-03-14 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by F-star Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-f-star-therapeutics-inc-4196013)
- 2023-03-09 14:21 UTC [SEC Form 4] [SEC Form 4: Kayitalire Louis returned $178,135 worth of shares to the company (25,019 units at $7.12), closing all direct ownership in the company to satisfy tax liability](https://www.quantisnow.com/insight/sec-form-4-kayitalire-louis-returned-178135-worth-of-shares-4179024)
- 2023-03-09 14:20 UTC [SEC Form 4] [SEC Form 4: Forster Eliot returned $526,588 worth of shares to the company (73,959 units at $7.12), closing all direct ownership in the company (for withholding tax)](https://www.quantisnow.com/insight/sec-form-4-forster-eliot-returned-526588-worth-of-shares-4179018)
- 2023-03-09 14:18 UTC [SEC Form 4] [SEC Form 4 filed by Klein Pamela M.](https://www.quantisnow.com/insight/sec-form-4-filed-by-klein-pamela-m-4179007)
- 2023-03-09 14:18 UTC [SEC Form 4] [SEC Form 4: Deptula-Hicks Darlene M returned $181,838 worth of shares to the company (25,539 units at $7.12), closing all direct ownership in the company to cover withholding tax](https://www.quantisnow.com/insight/sec-form-4-deptula-hicks-darlene-m-returned-181838-worth-of-4179006)
- 2023-03-09 14:17 UTC [SEC Form 4] [SEC Form 4: Brady Todd C closing all direct ownership in the company (withholding tax)](https://www.quantisnow.com/insight/sec-form-4-brady-todd-c-closing-all-direct-ownership-4179001)
- 2023-03-09 14:16 UTC [SEC Form 4] [SEC Form 4: Brewis Neil returned $66,750 worth of shares to the company (9,375 units at $7.12), closing all direct ownership in the company (for withholding tax)](https://www.quantisnow.com/insight/sec-form-4-brewis-neil-returned-66750-worth-of-shares-4178995)
- 2023-03-09 14:14 UTC [SEC Form 4] [SEC Form 4: Race Geoffrey closing all direct ownership in the company to cover taxes](https://www.quantisnow.com/insight/sec-form-4-race-geoffrey-closing-all-direct-ownership-in-4178987)
- 2023-03-09 14:12 UTC [SEC Form 4] [SEC Form 4: Benz Edward Jr returned $31,221 worth of shares to the company (4,385 units at $7.12), closing all direct ownership in the company (tax withholding)](https://www.quantisnow.com/insight/sec-form-4-benz-edward-jr-returned-31221-worth-of-4178959)
- 2023-03-09 14:12 UTC [SEC Form 4] [SEC Form 4: Bermingham Nessan returned $45,055 worth of shares to the company (6,328 units at $7.12), closing all direct ownership in the company (for tax liability)](https://www.quantisnow.com/insight/sec-form-4-bermingham-nessan-returned-45055-worth-of-shares-4178958)
- 2023-03-09 14:10 UTC [SEC Form 4] [SEC Form 4: Arkowitz David closing all direct ownership in the company (for withholding tax)](https://www.quantisnow.com/insight/sec-form-4-arkowitz-david-closing-all-direct-ownership-in-4178948)
- 2023-03-09 13:43 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by F-star Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-f-star-therapeutics-inc-4178512)
- 2023-03-09 13:42 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by F-star Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-f-star-therapeutics-inc-4178498)
- 2023-03-09 13:41 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by F-star Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-f-star-therapeutics-inc-4178491)
- 2023-03-09 13:40 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by F-star Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-f-star-therapeutics-inc-4178481)
- 2023-03-09 13:39 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by F-star Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-f-star-therapeutics-inc-4178473)
- 2023-03-09 13:38 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by F-star Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-f-star-therapeutics-inc-4178466)
- 2023-03-09 13:35 UTC [SEC Form POS AM filed by F-star Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-f-star-therapeutics-inc-4178458)
- 2023-03-09 13:36 UTC [SEC Form POS AM filed by F-star Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-f-star-therapeutics-inc-4178454)
- 2023-03-09 13:34 UTC [SEC Form POS AM filed by F-star Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-f-star-therapeutics-inc-4178439)
- 2023-03-09 13:32 UTC [SEC Form POS AM filed by F-star Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-f-star-therapeutics-inc-4178408)
- 2023-03-09 13:29 UTC [SEC Form POS AM filed by F-star Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-f-star-therapeutics-inc-4178386)
- 2023-03-09 13:27 UTC [SEC Form 8-K] [F-star Therapeutics Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits](https://www.quantisnow.com/insight/f-star-therapeutics-inc-filed-sec-form-8-k-completion-of-acquisition-4178287)
- 2023-03-09 13:24 UTC [SEC Schedule 14D-9] [SEC Form SC 14D9/A filed by F-star Therapeutics Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-14d9a-filed-by-f-star-therapeutics-inc-amendment-4178276)
- 2023-03-09 13:21 UTC [SEC Form 25-NSE filed by F-star Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-f-star-therapeutics-inc-4178261)
- 2023-03-09 00:30 UTC [Mergers & Acquisitions] [invoX Pharma Completes Acquisition of F-star Therapeutics, Inc.](https://www.quantisnow.com/insight/invox-pharma-completes-acquisition-of-f-star-therapeutics-inc-4176421)
- 2023-03-07 18:02 UTC [Market Insight] [Why Rivian Automotive Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session](https://www.quantisnow.com/insight/why-rivian-automotive-shares-are-trading-lower-by-over-10-4167300)
- 2023-03-07 15:25 UTC [Market Insight] [Why F-Star Therapeutics Shares Are Moving Higher](https://www.quantisnow.com/insight/why-f-star-therapeutics-shares-are-moving-higher-4166673)
- 2023-03-07 14:04 UTC [Market Chatter] [F-star Therapeutics Announces CFIUS Clearance For Proposed Acquisition By invoX Pharma](https://www.quantisnow.com/insight/f-star-therapeutics-announces-cfius-clearance-for-proposed-acquisition-by-invox-4166141)
- 2023-03-07 14:00 UTC [F-star Therapeutics Announces CFIUS Clearance for Proposed Acquisition  by invoX Pharma](https://www.quantisnow.com/insight/f-star-therapeutics-announces-cfius-clearance-for-proposed-acquisition-by-invox-4165817)
- 2023-03-07 13:06 UTC [Market Insight] [12 Health Care Stocks Moving In Tuesday's Pre-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-tuesdays-pre-market-session-4165445)
- 2023-02-23 13:45 UTC [SEC Form 8-K] [F-star Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/f-star-therapeutics-inc-filed-sec-form-8-k-entry-into-a-4105236)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/FSTX
- Earnings history: https://www.quantisnow.com/earnings/FSTX
- Dividend history: https://www.quantisnow.com/dividends/FSTX
- Insider transactions: https://www.quantisnow.com/insiders/FSTX
- Options chain: https://www.quantisnow.com/options/FSTX
- SEC 8-K filings only: https://www.quantisnow.com/company/FSTX/8-k
- RSS and alerts for FSTX: https://www.quantisnow.com/docs/rss-feeds.md